Long Non-Coding RNA AL139385.1 as a Novel Prognostic Biomarker in Lung Adenocarcinoma

被引:4
|
作者
Chen, Xi [1 ]
Guo, Jishu [2 ]
Zhou, Fan [3 ]
Ren, Wenjun [4 ]
Huang, Xiaobin [1 ]
Pu, Jun [1 ]
Niu, Xiaoqun [5 ]
Jiang, Xiulin [6 ]
机构
[1] Kunming Med Univ, Affiliated Hosp 2, Dept Neurosurg, Kunming, Peoples R China
[2] Yunnan Univ, Inst forEcol Res & Pollut Control Plateau Lakes, Sch Ecol & Environm Sci, Kunming, Peoples R China
[3] Puer Peoples Hosp, Hematol & Rheumatol Dept, Puer, Peoples R China
[4] First Peoples Hosp Yunnan Prov, Dept Cardiovasc Surg, Kunming, Peoples R China
[5] Kunming Med Univ, Second Hosp, Dept Resp Med, Kunming, Peoples R China
[6] Univ Chinese Acad Sci, Kunming Coll Life Sci, Beijing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词
AL139385; 1; lung adenocarcinoma; prognosis biomarker; DNA methylation; ceRNA; cell proliferation; cell migration; CELL-PROLIFERATION; CANCER; RETRACTION; EXPRESSION;
D O I
10.3389/fonc.2022.905871
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung adenocarcinoma (LUAD) is the most common histological lung cancer, and it is the leading cause of cancer-related deaths worldwide. LncRNA-AL139385.1 (ENSG00000275880) is a novel lncRNA that is abnormally expressed in various cancer types including LUAD. However, the underlying biological function and potential mechanisms of AL139385.1 driving the progression of LUAD remain unclear. In this study, we investigated the role of AL139385.1 in LUAD and found that DNA hypomethylation was positively correlated with AL139385.1 expression in LUAD. Moreover, we uncover that the expression of AL139385.1 in LUAD tissues was significantly higher than that of AL139385.1 expression in adjacent normal tissues. Kaplan-Meier survival analysis showed that patients with higher AL139385.1 expression correlated with adverse overall survival and progression-free survival. Receiver operating characteristic (ROC) curve analysis showed that the area under the curve (AUC) value of AL139385.1 was 0.808. Correlation analysis showed that AL139385.1 expression was associated with immune infiltration in LUAD. We also found that AL139385.1 was upregulated in LUAD cancer tissues and cell lines. Knockdown of AL139385.1 significantly inhibited cell proliferation and migration abilities of LUAD. Finally, we constructed a ceRNA network that includes hsa-miR-532-5p and four mRNAs (GALNT3, CYCS, EIF5A, and ITGB4) specific to AL139385.1 in LUAD. Subsequent Kaplan-Meier survival analysis suggested that polypeptide N-acetylgalactosaminyltransferase 3 (GALNT3), cytochrome c, somatic (CYCS), eukaryotic translation initiation factor 5A (EIF5A), and integrin subunit beta 4 (ITGB4), were potential prognostic biomarkers for patients with LUAD. In conclusion, this finding provides possible mechanisms underlying the abnormal upregulation of AL139385.1 as well as a comprehensive view of the AL139385.1-mediated competing endogenous RNAs (ceRNA) network in LUAD, thereby highlighting its potential role in diagnosis and therapy.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Unveiling the hidden gem: A review of long non-coding RNA NBAT-1 as an emerging tumor suppressor and prognostic biomarker in cancer
    Sethi, Subhash Chandra
    Singh, Ragini
    Sahay, Osheen
    Barik, Ganesh Kumar
    Kalita, Bhargab
    CELLULAR SIGNALLING, 2025, 126
  • [32] Long non-coding RNA-HAGLR suppressed tumor growth of lung adenocarcinoma through epigenetically silencing E2F1
    Guo, Xiaobin
    Chen, Zhuochang
    Zhao, Limin
    Cheng, Dongjun
    Song, Wei
    Zhang, Xiaoju
    EXPERIMENTAL CELL RESEARCH, 2019, 382 (01)
  • [33] Sputum long non-coding RNA biomarkers for diagnosis of lung cancer
    Gupta, Chhavi
    Su, Jian
    Zhan, Min
    Stass, Sanford A.
    Jiang, Feng
    CANCER BIOMARKERS, 2019, 26 (02) : 219 - 227
  • [34] Competing endogenous RNA (ceRNA ) hypothetic model based on comprehensive analysis of long non-coding RNA expression in lung adenocarcinoma
    Wang, Xiwen
    Su, Rui
    Guo, Qiqiang
    Liu, Jia
    Ruan, Banlai
    Wang, Guiling
    PEERJ, 2019, 7
  • [35] Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer
    Zhou, Xiaoying
    Yin, Chengqiang
    Dang, Yini
    Ye, Feng
    Zhang, Guoxin
    SCIENTIFIC REPORTS, 2015, 5
  • [36] Overexpression of Long Non-Coding RNA ZXF2 Promotes Lung Adenocarcinoma Progression Through c-Myc Pathway
    Yang, Ze-Tian
    Li, Zhihong
    Wang, Xian-Guo
    Tan, Tao
    Yi, Frank
    Zhu, Hua
    Zhao, Jin-Ping
    Zhou, Xue-Feng
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 35 (06) : 2360 - 2370
  • [37] Long non-coding RNA Linc00261 as a novel potential diagnostic and prognostic biomarker for gallbladder cancer
    Niu, Jia-Zeng
    Liang, Xian-Chun
    Xu, Zhou-Wei
    Li, Zhen-Huan
    Li, Ji
    Meng, Yong
    Sun, Zhi-Wei
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (10) : 6078 - 6085
  • [38] Long non-coding RNA LINC01296 is a potential prognostic biomarker in patients with colorectal cancer
    Qiu, Jia-jun
    Yan, Jing-bin
    TUMOR BIOLOGY, 2015, 36 (09) : 7175 - 7183
  • [39] Long non-coding RNA H19 as a prognostic biomarker for oral squamous cell carcinoma
    Kumar, Kiran
    Hallikeri, Kaveri
    Oli, Ajay Kumar
    Radder, Kiran
    Jain, Apoorva
    Shilpasree, A. S.
    Dhanapal, Raghu
    Tabnjh, Abedelmalek Kalefh
    Selvaraj, Siddharthan
    FRONTIERS IN MEDICINE, 2024, 11
  • [40] Non-coding RNA and lung cancer progression
    Ishola, Afeez Adekunle
    La'ah, Anita Silas
    Le, Hung Dinh
    Nguyen, Viet Quoc
    Yang, Yi-Ping
    Chou, Shih-Jie
    Tai, Hsiao-Yun
    Chien, Chian-Shiu
    Wang, Mong-Lien
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2020, 83 (01) : 8 - 14